1. Home
  2. ZWS vs RGEN Comparison

ZWS vs RGEN Comparison

Compare ZWS & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zurn Elkay Water Solutions Corporation

ZWS

Zurn Elkay Water Solutions Corporation

HOLD

Current Price

$44.08

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$117.44

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZWS
RGEN
Founded
1892
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
8.1B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
ZWS
RGEN
Price
$44.08
$117.44
Analyst Decision
Buy
Buy
Analyst Count
6
11
Target Price
$49.33
$173.09
AVG Volume (30 Days)
672.8K
849.0K
Earning Date
04-21-2026
04-28-2026
Dividend Yield
0.99%
N/A
EPS Growth
25.00
286.96
EPS
1.15
0.86
Revenue
$1,530,500,000.00
$141,236,000.00
Revenue This Year
$6.90
$14.11
Revenue Next Year
$5.13
$14.71
P/E Ratio
$38.56
$136.91
Revenue Growth
19.40
35.10
52 Week Low
$27.74
$102.97
52 Week High
$53.17
$175.77

Technical Indicators

Market Signals
Indicator
ZWS
RGEN
Relative Strength Index (RSI) 22.08 36.65
Support Level $35.40 $112.97
Resistance Level $45.83 $132.51
Average True Range (ATR) 1.29 4.80
MACD -0.56 0.42
Stochastic Oscillator 9.38 35.92

Price Performance

Historical Comparison
ZWS
RGEN

About ZWS Zurn Elkay Water Solutions Corporation

Zurn Elkay Water Solutions Corp is a growth-oriented, pure-play water management business that designs, procures, manufactures, and markets the broadest sustainable product portfolio of specification-driven water management solutions to improve health, hydration, human safety and the environment. Its product portfolio includes professional grade water safety and control products, flow systems products, hygienic and environmental products, and filtered drinking water products for public and private spaces that deliver superior value to building owners, positively impact the environment and human hygiene and reduce product installation time.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: